Publicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (19)

2021

  1. The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design

    Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 3, pp. 164-176

2019

  1. CIBERSAM: Ten years of collaborative translational research in mental disorders

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 1, pp. 1-8

  2. Opioid Activity in the Locus Coeruleus Is Modulated by Chronic Neuropathic Pain

    Molecular Neurobiology, Vol. 56, Núm. 6, pp. 4135-4150

2018

  1. The complex association between the antioxidant defense system and clinical status in early psychosis

    PLoS ONE, Vol. 13, Núm. 4

2017

  1. Activation of Extracellular Signal-Regulated Kinases (ERK 1/2) in the Locus Coeruleus Contributes to Pain-Related Anxiety in Arthritic Male Rats

    International Journal of Neuropsychopharmacology, Vol. 20, Núm. 6, pp. 463-475

2014

  1. Basal low antioxidant capacity correlates with cognitive deficits in early onset psychosis. A 2-year follow-up study

    Schizophrenia Research, Vol. 156, Núm. 1, pp. 23-29

2013

  1. Chronic pain leads to concomitant noradrenergic impairment and mood disorders

    Biological Psychiatry, Vol. 73, Núm. 1, pp. 54-62

  2. Factors associated with chronic pain in patients with bipolar depression: A cross-sectional study

    BMC Psychiatry, Vol. 13

  3. L-DOPA modifies the antidepressant-like effects of reboxetine and fluoxetine in rats

    Neuropharmacology, Vol. 67, pp. 349-358

2012

  1. Antioxidant defense system and family environment in adolescents with family history of psychosis

    BMC Psychiatry, Vol. 12

  2. Cognitive impairment is related to oxidative stress and chemokine levels in first psychotic episodes

    Schizophrenia Research, Vol. 137, Núm. 1-3, pp. 66-72

  3. The function of alpha-2-adrenoceptors in the rat locus coeruleus is preserved in the chronic constriction injury model of neuropathic pain

    Psychopharmacology, Vol. 221, Núm. 1, pp. 53-65

2011

  1. Adverse drug events in older adults: Development of a predictive model

    Journal of the American Geriatrics Society

  2. Reduced antioxidant defense in early onset first-episode psychosis: A case-control study

    BMC Psychiatry, Vol. 11

2010

  1. Bases neurobiológicas del efecto antidepresivo de la quetiapina en el trastorno bipolar

    Actas Espanolas de Psiquiatria, Vol. 38, Núm. 1, pp. 22-32

2008

  1. LEVODOPA ALTERS THE ANTI DEPRESSANT-LIKE EFFECT OF FLUOXETINE AND REBOXETINE IN THE MODIFIED FORCED SWIMMING TEST IN RATS

    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

2004

  1. Effect of the antidepressant nefazodone on the density of cells expressing mu-opioid receptors in discrete brain areas processing sensory and affective dimensions of pain

    Psychopharmacology, Vol. 176, Núm. 3-4, pp. 305-311

  2. The role of age in the development of Schneiderian symptoms in patients with a first psychotic episode

    Acta Psychiatrica Scandinavica, Vol. 109, Núm. 4, pp. 264-268

2003

  1. Age-dependence of Schneiderian psychotic symptoms in bipolar patients

    Schizophrenia Research, Vol. 61, Núm. 2-3, pp. 157-162